PEDIATRICS Vol. 65 No. 2 February 1980, pp. 301-302
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chhattriwalla, Y.
Right arrow Articles by Scanlon, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chhattriwalla, Y.
Right arrow Articles by Scanlon, J. W.

The Use of Cimetidine in the Newborn

Yousuf Chhattriwalla MD1, A. R. Colon MD1, and John W. Scanlon MD1

1 Division of Neonatology, Columbia Hospital for Women, and Department of Pediatrics, Georgetown University School of Medicine, Washington, DC

Although uncommon, reflux esophagitis and gastric and duodenal ulcer disease have all been reported to occur in the newborn period.1,2 Cimetidine, a competitive antagonist specific for the histamine H2-receptor, has been demonstrated effective in reducing gastric acidity in the adult. Its neonatal use has not been reported.

The following cases suggest that cimetidine may be beneficial for the newborn with such disorders.

CASE REPORTS

Case 1

Baby L. weighed 740 gm at birth, was at 28 weeks gestation, and had prolonged, severe respiratory illness requiring ventilatory assistance. Repeated attempts at feedings, which began at 6 weeks of age, were associated with regurgitation, abdominal distention, and melenetic gastric aspirates. An upper gastrointestinal (GI) x-ray series confirmed reflux esophagitis. At 8 weeks of age cimetidine treatment was started at a dose of 10 mg/kg/day. The drug was continued for three weeks.

Within one week of the initiation of cimetidine therapy, there was a significant reduction in the frequency of vomiting and abdominal distention and the upper GI bleeding disappeared. There were no neurologic abnormalities noted on serial examinations performed during cimetidine therapy. There were also no changes in renal and liver function studies, or hematologic values associated with drug use.

Case 2

Baby G. was born at 27 weeks gestation and weighed 820 gm. He had severe respiratory distress and required ventilatory assistance. At 3 weeks of age, bronchopulmonary dysplasia was diagnosed by x-ray and by tracheal cytology. Because of clinical deterioration from this process, the baby was started on therapy with corticosteroids at 24 days of age.

Submitted on May 3, 1979
Accepted on July 3, 1979




This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
R. G. Dillard
Fatal Gastrointestinal Hemorrhage in a Neonate Treated with Tolazoline
Clinical Pediatrics, December 1, 1982; 21(12): 761 - 762.
[PDF]